IBAB Ion Beam Applications SA

New generation steps up to continue IBA’s entrepreneurial ownership

New generation steps up to continue IBA’s entrepreneurial ownership




Louvain-la-Neuve, Belgium, 5 December 2024 - IBA (Ion Beam Applications SA), the world leader in particle accelerator technology, announces today an initiative aimed at perpetuating the entrepreneurial anchoring of its shareholder base. A new generation of executives will acquire a significant indirect stake in IBA. It is part of a broader strategy to ensure IBA's growth, value creation and sustainability. Company’s success originates from a unique combination between entrepreneurial driving force and reference shareholding.

The operation consists of different steps (detailed in appendix) involving the support of IBA allowing Management Anchorage, a holding investment vehicle created by IBA executives in 2020, to acquire a 21% stake in Sustainable Anchorage. Sustainable Anchorage would remain IBA's reference shareholder with approximately 20% of the shares and 30% of the voting rights.

IBA supports and welcomes the commitment of a new generation of executives to invest in the company’s future. It reflects IBA’s ambition to reinforce its stable entrepreneurial shareholding structure, fully aligned with company’s long-term purpose and core values, while serving as a powerful lever for motivation, talent retention, and long-term value creation.

Completion of the operation is, among other things, subject to acceptance of the payment facilities by IBA's shareholders meeting convened on 7 January 2025. If this condition is met, the transaction will be executed shortly after the obtaining of this approval.

“Together with the employees of the time, we created Sustainable Anchorage to preserve IBA’s integrity against hostile takeover ambitions in 1999. For 25 years, Sustainable Anchorage has been instrumental for IBA’s successful development into a world leader allowing a strong alignment between shareholders and management powered by a shared long-term vision and common human and entrepreneurial values" explains Pierre Mottet, Chairman of the board of IBA and co-founder of Sustainable Anchorage.

For Henri de Romrée, Deputy CEO of IBA, “the creation of Management Anchorage four years ago responds to the same aspirations as those of Sustainable Anchorage. Its goal is to perpetuate the DNA and long-term vision of IBA, to foster initiative taking from its employees, and to share with them the value created.”

“I am energized by the commitment of the new management generations to continue IBA's reference shareholding” comments Olivier Legrain, CEO of IBA. “Their determination, their enthusiasm and their strong stand for our core values and ambitions are inspiring”. This initiative further consolidates our position as an independent leader, and a globally recognized expert in our fields of activity.”

***ENDS***

For more details on the terms of this transaction, please refer to the .



About IBA

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,000 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at:

About Management Anchorage

Management Anchorage SRL is a holding investment vehicle created by IBA executives in February 2020 to give them the opportunity to invest collectively in IBA's capital, considering the determining importance of the connection between company's driving forces and its shareholding.

On 30 August 2021, Management Anchorage acquired 348,530 IBA shares, representing 1.16% of the total number of shares issued by IBA, corresponding to 1.72% of the voting rights since 30 August 2023, after the expiry of the two-year holding period stipulated in IBA’s bylaws.

About Sustainable Anchorage

Sustainable Anchorage SA is a holding investment vehicle created by IBA founders and employees in 1999 to invest collectively in IBA’s capital and thereby safeguard company’s integrity, mission and values. With 20.49% of share capital and 30.42% of voting rights1, Sustainable Anchorage is IBA's main reference shareholder.

For further information:



Henri de Romrée

Deputy Chief Executive Officer

IBA



Olivier Lechien

Corporate Communication Director

IBA





For media and investor enquiries:

ICR Healthcare

Amber Fennell, Angela Gray, Lucy Featherstone

+44 (0) 20 3709 5700







1 Reference date : 11 September 2024



Attachment



EN
05/12/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ion Beam Applications SA

Guy Sips ... (+9)
  • Guy Sips
  • Hilde Van Boxstael
  • Kristof Samoy
  • Mathijs Geerts Danau
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

Morning Notes : ABI BB, AGN NA, ARCAD NA, BESI NA, ENX FP, GIMB BB, HY...

: ABI BB, AGN NA, ARCAD NA, BESI NA, ENX FP, GIMB BB, HYL BB, IBAB BB, KIN BB, MTLS US, VGP BB, AZE BB, ZEAL DC

 PRESS RELEASE

IBA and Shreeji sign multi‑site agreement for four cyclotrons to expan...

IBA and Shreeji sign multi‑site agreement for four cyclotrons to expand PET radiopharmaceutical manufacturing across India Louvain-la-Neuve, Belgium – 19 February 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology with a preeminent position in nuclear medicine, and Shreeji (Shreeji Imaging and Diagnostic Centre Pvt. Ltd.), a leading Indian manufacturer and distributor of fluorodeoxyglucose (FDG) and positron emission tomography (PET) radiopharmaceuticals, have signed a multi-site agreement for the delivery and installation of four mid-en...

 PRESS RELEASE

IBA et Shreeji signent un accord pour quatre cyclotrons afin d’étendre...

IBA et Shreeji signent un accord pour quatre cyclotrons afin d’étendre la production de radiopharmaceutiques TEP en Inde Louvain-la-Neuve, Belgium – 19 février 2026 – IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d'accélérateurs de particules et acteur de premier plan en médecine nucléaire, et Shreeji (Shreeji Imaging and Diagnostic Centre Pvt. Ltd.), l'un des principaux fabricants et distributeurs indiens de fluorodéoxyglucose (FDG) et de radiopharmaceutiques pour la tomographie par émission de positons (TEP), ont signé un contrat pour la livraison et l'i...

 PRESS RELEASE

IBA – ACQUISITION OF OWN SHARES

IBA – ACQUISITION OF OWN SHARES Louvain-la-Neuve, Belgium, February 16th, 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026. Under this program, IBA has requested a financial intermediary to repurchase up to 400,000 IBA ordinary shares on its behalf under the terms of a mandate with validity until September 30th, 2026 (included), effective as from February 3rd, 2...

 PRESS RELEASE

IBA – ACQUISITION D’ACTIONS PROPRES

IBA – ACQUISITION D’ACTIONS PROPRES Louvain-la-Neuve, Belgique, 16 février 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") communique par la présente certaines informations relatives à son programme de rachat d'actions annoncé le 2 février 2026. Dans le cadre de ce programme, IBA a demandé à un intermédiaire financier de racheter en son nom un maximum de 400.000 actions ordinaires IBA selon les termes d'un mandat valable jusqu'au 30 septembre 2026 et effectif ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch